High‐risk cytogenetic abnormalities in multiple myeloma: PETHEMA‐GEM experience

Abstract This study examines the impact of cytogenetic abnormalities and their co‐segregation on the prognosis of newly diagnosed multiple myeloma patients. The analysis included 1304 patients from four different GEM‐PETHEMA clinical trials. Genetic alterations, such as t(4;14), t(14;16), del(17p),...

Full description

Bibliographic Details
Published in:HemaSphere
Main Authors: Veronica González‐Calle, Paula Rodriguez‐Otero, Maria J. Calasanz, Manuela Guijarro, Joaquin Martínez‐López, Laura Rosiñol, Miguel T. Hernández, Ana I. Teruel, Mercedes Gironella, Albert Oriol, Javier de laRubia, Ana P. González‐Rodríguez, Joan Bargay, Felipe deArriba, Luis Palomera, Marta‐Sonia González‐Pérez, Anna Sureda, Enrique Ocio, Juan J. Lahuerta, Joan Bladé, Jesus F. San Miguel, Maria V. Mateos, Norma C. Gutiérrez
Format: Article
Language:English
Published: Wiley 2024-12-01
Online Access:https://doi.org/10.1002/hem3.70031

Internet

https://doi.org/10.1002/hem3.70031

Similar Items